Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The ATP-sensitive potassium channel regulatory subunit SUR1 is a regulatory component of the K_ATP channel, an octameric complex of four Kir6.2 and four SUR1 subunits. It regulates the K_ATP channel's activity by linking cellular metabolism to membrane excitability. SUR1 is the molecular target of sulfonylurea drugs used in type 2 diabetes. Mutations in ABCC8/SUR1 can cause congenital hyperinsulinism or neonatal diabetes. Additionally, SUR1 plays a role in cardiac tissue under stress.
Sulfonylureas and glinides bind to SUR1, causing closure of K_ATP channels in pancreatic beta cells, leading to depolarization and insulin release.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP-sensitive potassium channel regulatory subunit SUR1 (SUR1).